Résultats de la recherche - 2 results
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
mRNA vaccine compared to adenoviral-vectored vaccine reduced the risk of being seronegative by 90%. Health Topics: Coronavirus Coronavirus Coronavirus Service: Information sanitaire ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
antibodies than people vaccinated with a vector-borne vaccine (AstraZeneca, Johnson&Johnson). In the not vaccinated population, people with a blood type O are less likely to have anti- SARS-CoV‑2 ...